Latest News

Friday, November 09, 2018

Cutanea Life Sciences Launches Xepi Cream

Cutanea Life Sciences, Inc. has launched Xepi™ (ozenoxacin) Cream, 1% for the treatment of impetigo in adult and pediatric patients two months of age or older. Xepi is a non-fluorinated top…

Read the full story

Thursday, November 08, 2018

The American Dermatological Association Is On Board with American Cancer Society's HPV Vaccine Policy

The American Dermatological Association is co-sponsoring the American Cancer Society’s public policy of vaccination against Human Papillomavirus infections [HPV] beginning at age 11 or 12 for gi…

Read the full story

Wednesday, November 07, 2018

Ortho Dermatologics Gears Up to Launch Bryhali Lotion for Plaque Psoriasis

Ortho Dermatologics expects to start distribution of Bryhali (halobetsasol propionate) Lotion, 0.01%, to U.S. wholesale pharmaceutical distributors later this month. The company received final appr…

Read the full story

Wednesday, November 07, 2018

Study: Fine Water Particle Sprays Improve Facial Skin Moisture for Hours

Spraying fine water particles onto the face in winter, when skin is dry, improved skin hydration and softening, according to a new study in Skin Research & Technology. In addition, water r…

Read the full story

Wednesday, November 07, 2018

Endo’s CCH Improves Appearance of Cellulite in Buttocks

Endo International plc’s clostridium histolyticum (CCH) performed well in two identical Phase 3 studies for the treatment of cellulite in the buttocks. Subjects receiving CCH showed highly st…

Read the full story

Tuesday, November 06, 2018

US FDA Grants Dupixent Priority Review for Moderate-to-Severe AD in Adolescents

The US Food and Drug Administration (FDA) has granted Priority Review for Dupixent (dupilumab) as a potential treatment for adolescents with uncontrolled moderate-to-severe atopic dermatitis (AD). …

Read the full story

Monday, November 05, 2018

FDA Approves Galderma’s Restylane Lyft for Midface Injection Via Cannula

The U.S. Food and Drug Administration (FDA) has approved the use of Galderma’s Restylane Lyft with a small, blunt-tip cannula for cheek augmentation and the correction of age-related midface con…

Read the full story

Friday, November 02, 2018

November is Hyperhidrosis Awareness Month

November is Hyperhidrosis Awareness Month. The International Hyperhidrosis Society (IHhS) wants the world to know that hyperhidrosis’ (Hh) uncontrollable, no-fault sweating can soak through clot…

Read the full story

Friday, November 02, 2018

Mayne Pharma Acquires FDA-approved Halobetasol Foam

Mayne Pharma has acquired the US and Australian rights to halobetasol foam 0.05% for an investment of up to $32 million (comprising $10 million in cash up front, $5 million at commercial launch plus c…

Read the full story

Thursday, November 01, 2018

Endocannabinoids Effective in Lupus Model

Zylö Therapeutics’ patented Nanopod™ aerogel delivery technology was used to demonstrate the efficacy of endocannabinoids in a model of cutaneous lupus in a study presented last month…

Read the full story

Thursday, November 01, 2018

AAD Releases New Melanoma Guidelines

As National Healthy Skin Month begins, the American Academy of Dermatology’s (AAD) new melanoma guidelines shed light on risk of melanoma prognosis during pregnancy, the role of formal gene…

Read the full story

Wednesday, October 31, 2018

Cooling Caps and Other Cooling Methods May Prevent Taxane-Induced Dermatologic Events

Cooling therapies such as cold caps, scalp cooling systems, frozen gloves, and frozen socks may offer the best protection against the adverse effects of taxane-based chemotherapy, according to a new s…

Read the full story

Tuesday, October 30, 2018

New AD Estimate: As Many As 16.5 Million Adults Have AD

As many as 16.5 million adults in America have atopic dermatitis (AD). This estimate comes from a new study from the Perelman School of Medicine at the University of Pennsylvania, which also projec…

Read the full story

Tuesday, October 30, 2018

Alastin Receives Patent for TriHex Technology

Alastin Skincare, Inc. received a patent for their TriHex Technology.   Specifically, the United States Patent and Trademark Office issued U.S. Patent No. 10,086,035 entitled “…

Read the full story

Tuesday, October 30, 2018

Ortho Dermatologics' Altreno Now Available in the US

Ortho Dermatologics launched Altreno (tretinoin) Lotion, 0.05% for the topical treatment of acne vulgaris in patients 9 years of age and older. Altreno Lotion is the first and only tretinoin available…

Read the full story
Load More